Trials / Completed
CompletedNCT01568385
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Takeda · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to study the safety and efficacy of TAK-438, once daily (QD), in participants with a history of gastric or duodenal ulcer requiring long-term NSAID therapy will be investigated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TAK-438 |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2012-04-02
- Last updated
- 2014-02-10
Locations
18 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01568385. Inclusion in this directory is not an endorsement.